USPTO serial 79449384
LIBERTY ENDOVASCULAR ROBOTIC SYSTEM
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- STEINPFAD, SARAH E
- Law office
- TMO LAW OFFICE 120
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with LIBERTY ENDOVASCULAR ROBOTIC SYSTEM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | A robotic medical system consisting of medical device, communication means, data storage, controller and medical instruments for automated endovascular procedures (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); a robotic medical system consisting of medical device, communication means, controller and medical instruments for automated endovascular procedures (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); a robotic medical system consisting of medical device, communication means, data storage, controller and medical instruments for advancing and navigating of medical instruments in endovascular medical procedures (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); a robotic medical system consisting of medical device, communication means, controller and medical instruments for advancing and navigating of medical instruments in endovascular medical procedures (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); a robotic medical system consisting of medical device, communication means, data storage, controller and medical instruments for advancement, navigation and placement of guide wires and/or catheters in endovascular medical procedures (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); a robotic medical system consisting of medical device, communication means, controller and medical instruments for advancement, navigation and placement of guide wires and/or catheters in endovascular medical procedures (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); a robotic medical system consisting of medical device, communication means, data storage, con troller and medical instruments for advancement, navigation and placement of guide wires and/or catheters in endovascular procedures, namely, coronary, peripheral and cerebral endovascular procedures (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); robotically controlled drive mechanism for use in endovascular medical procedures (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); a medical device, namely, a remote manipulation system consisting of a robotic device, to facilitate remote advancement, navigation and placement of medical instruments in endovascular medical procedures (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); a medical device, namely, a tele-robotic system consisting of a motorized advancement and navigation device having rotational and translational movement capabilities to facilitate remote advancement, navigation and placement of medical instruments, namely, guide wires and/or catheters (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); bedside robotic medical system consisting of medical device, communication means, data storage, controller and medical instruments for advancement, navigation and placement of medical instruments in endovascular medical procedures (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); bedside robotic medical system consisting of medical device, communication means, controller and medical instruments for advancement, navigation and placement of medical instruments in endovascular medical procedures (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); body-mountable robotic medical system consisting of medical device, communication means, data storage, controller and medical instruments for advancement, navigation and placement of medical instruments in endovascular medical procedures (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); body-mountable robotic medical system consisting of medical device, communication means, controller and medical instruments for advancement, navigation and placement of medical instruments in endovascular medical procedures (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations). | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 17, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 30, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 30, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 23, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 22, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 9, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| May 8, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 8, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 7, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |